FINWIRES · TerminalLIVE
FINWIRES

DexCom Long-Range Plan Establishes Respectable Base Case, RBC Says

By

DexCom's (DXCM) long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.

The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.

DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.

RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS growth of about 11.9% and 18.2%, respectively.

RBC kept an outperform rating on DexCom with a price target of $85.

Shares of DexCom rose by nearly 7% in Friday trading.

Price: $61.70, Change: $+3.88, Percent Change: +6.71%

Related Articles

Wire

Aardvark Therapeutics' Investigational New Drug Application for ARD-101 Put on Clinical Hold by FDA

Aardvark Therapeutics (AARD) said late Thursday the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101 to treat hyperphagia associated with Prader-Willi Syndrome.The hold applies to all ongoing clinical studies under the IND, the company said, adding that it is in discussions with the FDA for resolution of the clinical hold and to fix a path forward for the drug candidate.The company also plans to unblind clinical data from the HERO and OLE trials to assess the totality of efficacy and safety data, according to the company.The company said it had $91.2 million in cash and cash equivalents as of March 31, adequate to fund operations into mid-2027.

$AARD
Wire

Sky Harbour Q1 Loss Narrows, Revenue Rises; Shares Fall After Hours

Sky Harbour Group (SKYH) reported a Q1 loss late Thursday of $0.16 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by FactSet expected a loss of $0.13.Revenue in the three months ended March 31 rose to $8.73 million from $5.59 million a year earlier.Analysts surveyed by FactSet expected $9.8 million.Sky Harbour shares fell 4.9% in after-hours trading.

$SKYH
Wire

KinderCare Learning Q1 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

KinderCare Learning (KLC) reported Q1 adjusted earnings late Thursday of $0.04 per diluted share, down from $0.23 a year earlier.Analysts surveyed by FactSet expected a loss of $0.01.Revenue in the three months ended April 4 rose to $672.5 million from $668.2 million a year earlier.Analysts surveyed by FactSet expected $669.1 million.The company boosted full-year adjusted EPS guidance to $0.15 to $0.25 from the previous forecast of $0.10 to $0.20. It affirmed the revenue outlook of $2.7 billion to $2.75 billion.Analysts expect EPS of $0.15 on revenue of $2.71 billion.KinderCare shares fell 6.2% in after-hours trading.

$KLC